Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Research shows that roughly 70% of people who stop taking GLP-1 medications like Mounjaro regain two-thirds of their lost weight within a year. The challenge isn't losing weight—it's keeping it off once treatment ends. PlexusDx helps patients maintain their results through continuous, affordable tirzepatide therapy tailored to individual genetic responses.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

What Happens to Your Weight After Mounjaro Treatment Ends

Tirzepatide, the active ingredient in Mounjaro, works by mimicking hormones that regulate appetite and blood sugar. When you stop the medication, your body's hunger signals and metabolic rate gradually return to baseline over weeks to months. During this transition, many patients experience increased cravings and calorie consumption, leading to rapid weight rebound.

Clinical trials tracking patients after tirzepatide discontinuation found that weight regain begins almost immediately—sometimes within 4 to 12 weeks. This isn't a personal failure; it reflects how powerfully these medications influence the brain centers that control eating behavior. Your body essentially 'remembers' its pre-treatment weight set point and actively works to return to it.

Why Long-Term Tirzepatide Therapy Prevents Weight Regain

Continuing tirzepatide therapy addresses the root cause of rebound weight gain: your body's biological drive to return to a higher weight. Rather than stopping suddenly, PlexusDx patients maintain steady tirzepatide doses that sustain appetite suppression and metabolic improvements. This approach aligns with how cardiologists treat high blood pressure or diabetes—as a chronic condition requiring ongoing management.

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan, with no flat per-compound pricing increases. Your dose may need to go up. Your price won't. This flat-rate model removes financial barriers to staying on medication long-term, which is essential for maintaining weight loss success.

Genetic Factors That Influence Your Ability to Keep Weight Off

Not everyone regains weight at the same rate after stopping tirzepatide. Genetic variations in the GLP-1 receptor (GLP1R rs6923761), GIPR pathway (rs1800437), and metabolic genes like FTO (rs9939609) all influence how your body responds to medication discontinuation. Some people maintain weight loss naturally; others require indefinite treatment to prevent rebound.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Strategies to Keep Weight Off Alongside Tirzepatide

Medication alone doesn't guarantee permanent weight loss. Maintaining your results requires behavioral changes that persist even if tirzepatide doses decrease. Focus on protein intake (25–30% of daily calories), regular physical activity, and consistent sleep patterns. These habits reinforce the appetite suppression and metabolic benefits tirzepatide provides.

Many PlexusDx patients find that continuing lower-maintenance doses long-term—rather than stopping completely—offers the best balance between results and cost. Since PlexusDx compounded tirzepatide carries a flat monthly rate at $289/mo month-to-month, or from $249/mo on the 6-month plan, you can discuss dose tapering with your provider without worrying about escalating costs. This flexibility supports sustainable weight management over years, not just months.

PlexusDx's Model for Sustaining Long-Term Weight Loss Success

PlexusDx serves all 50 states without insurance requirements or membership fees, making long-term tirzepatide therapy accessible to more patients. Your compounded tirzepatide comes from licensed 503A compounding pharmacies—the gold standard for sterility and quality—ensuring you receive pharmaceutical-grade medication at a fraction of brand-name costs.

HSA and FSA accounts cover PlexusDx medications, further lowering out-of-pocket expense. When you combine affordable pricing, no insurance gatekeeping, and personalized genetic testing, continuing tirzepatide therapy becomes a realistic option for preventing weight regain. Most patients find that staying on tirzepatide indefinitely costs less than the medical consequences of cycling on and off—including diet attempts, potential regain-related complications, and repeated cycles of motivation and disappointment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I have to stay on tirzepatide forever to keep weight off?

Not necessarily. PlexusDx's Precision Peptide Genetic Test reveals whether your biology predisposes you to weight regain or permits stable maintenance off medication. For some patients, genetic markers suggest you can safely taper; for others, indefinite low-dose therapy prevents rebound. Your provider can guide this decision based on your results and clinical response.

How much weight do people typically regain after stopping Mounjaro?

Clinical data shows most patients regain 50–70% of their lost weight within 12 months after stopping tirzepatide. Regain typically begins within 4–12 weeks. This timeline varies by genetics, lifestyle, and baseline metabolic health. Continuing tirzepatide therapy essentially halts this regain process.

What is PlexusDx's tirzepatide cost, and does it increase if my dose goes up?

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan—a flat rate across all doses. Your dose may need to go up. Your price won't. This pricing model is unique and removes financial barriers to dose adjustments as your provider optimizes your therapy.

Is compounded tirzepatide as safe as brand-name Mounjaro?

PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow FDA manufacturing standards and undergo rigorous quality testing. While compounded medications aren't FDA-approved, 503A pharmacy-compounded tirzepatide has the same active ingredient and similar purity standards as brand products, at significantly lower cost.

What does PlexusDx's Precision Peptide Genetic Test tell me about weight maintenance?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves